Latest Novartis News & Updates

See the latest news and media coverage for Novartis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Novartis

Innovative medicines company

novartis.com
Headquarters
Basel, Switzerland
Company type
Public company
Number of employees
80,000+

Latest news about Novartis

Company announcements

  • Novartis

    Novartis finalizes US manufacturing and R&D expansion

    Announces seventh new facility in North Carolina for API manufacturing, completing $23 billion investment plan. Strengthens end-to-end US production for innovative medicines.

  • Novartis

    Novartis delivers strong Q1 growth in priority brands

    Net sales decline 5% due to generic erosion, but brands like Kisqali and Pluvicto grow strongly. FY 2026 guidance reaffirmed. Acquisition of Avidity completed.

  • Novartis

    Novartis Rhapsido receives European Commission approval

    It is the first oral targeted treatment for chronic spontaneous urticaria in adults inadequately responding to H1-antihistamines. Studies show rapid improvements and favorable safety.

  • Novartis

    Novartis withdraws EMA application for Pluvicto new indication

    Withdrawal follows CHMP feedback on PSMAfore study control arm. It does not affect quality, efficacy, safety, trials, or approvals. Pluvicto approved in US, Japan, China.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Novartis

Track Novartis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novartis competitors & trending companies

Browse news for competitors to Novartis and other trending companies.